ELRIG events

Call for Abstracts:  Send us your talks for a potential Podium Presentation

Submit a Talk Title, brief summary and your contact details to This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Deadline  -  29^th July 2013

Make sure you let us know it is for the ‘Recombinant Protein Technology’ show

Topic areas:  Proteins OR Cells

CONFERENCE OVERVIEW

The ability to produce proteins (as reagents or biotherapeutics) of sufficient quality and quantity is important for the academic and industrial sectors. The use of eukaryotic cells as hosts for expression and recovery of recombinant cellular, membrane or secreted proteins has developed markedly over the past decade. This conference brings together academic and industrial researchers working on eukaryotic cells as protein expression hosts, and will address our current fundamental understanding about molecular events that determine productivity and quality attributes in the use of specific cell hosts for specific protein product categories. 

In particular, the conference will focus on the biology of existing host cells (in terms of competencies for protein expression), structural features associated with success of expression of specific proteins (including the relationships between specific proteins and host cells) and how both host cell and desired proteins may be engineered to generate new (synthetic) systems for enhanced product expression. The two day conference will consist of presentations by plenary speakers, workshop sessions with invited speakers and speakers selected from offered abstracts and a poster session. Participation will be strictly limited to 220 attendees to enable networking and informal discussion. 

A meeting jointly organised by AstraZeneca, University of Manchester and ELRIG

Delegate Registration is now OPEN.... follow the top Registration bar or click here......

Exhibitors:  To view the floor plan and book your stand -  click here

Posters:  Please submit your Poster Abstract to  This e-mail address is being protected from spambots. You need JavaScript enabled to view it  

Read more: Advances in Recombinant Protein Technology 2013